Interstate Blood Bank
Interstate Blood Bank, Inc. (IBBI) is a US-based subsidiary of Grifols, S.A. that operates a network of blood donor centers collecting whole blood from compensated individual donors, screens each donation for infectious diseases at its Memphis, TN testing facility, and supplies the tested product to therapeutic and diagnostic industry buyers.
- Company typePrivate
- Founded1949
- HeadquartersMemphis, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Interstate Blood Bank does
Interstate Blood Bank, Inc. (IBBI) is a US-based whole blood collection and supply company headquartered in Memphis, Tennessee, founded in 1949 and operating as a wholly-owned subsidiary of Grifols, S.A. since the 2019 acquisition. The company operates a multi-state network of physical blood donor centers where individual donors aged 18–70 and weighing at least 110 pounds donate whole blood in approximately 30-minute sessions, with donors compensated for their time and limited to one donation per 8-week period. Walk-in donation is supported at all sites, and a ZIP-code-based locator drives discovery across the network.
IBBI's core technology stack is conventional: physical donor centers, on-site pre-donation screening using routine medical-history questionnaires, and centralized state-of-the-art testing facilities in Memphis, TN where laboratory technicians conduct extensive infectious-disease screening on every donation collected. The Memphis facility performs over 2 million tests annually, screening each unit for Hepatitis B, Hepatitis C, HIV, and Syphilis. There is no disclosed AI/ML, app, API, or third-party platform integration in the data; distribution of collected product is conducted off-platform through B2B channels.
The revenue model is a transaction-fee whole blood collection and distribution business. IBBI earns by collecting whole blood from compensated donors, processing and testing it, and supplying screened product to therapeutic and diagnostic industry buyers who use it in the production of testing and diagnostic tools. Customer segmentation is horizontal across the therapeutic and diagnostic industries, with end-buyers being enterprise-scale manufacturers rather than individual consumers. Revenue mechanics are not publicly disclosed at the subsidiary level, and pricing for donor compensation is set per location and not listed publicly. The company is private, operates only in the United States, and is reported as actively operating within Grifols' broader plasma and blood products network.
Interstate Blood Bank firmographics
Firmographics- Name
- Interstate Blood Bank
- Legal name
- Interstate Blood Bank, Inc.
- Website
- https://interstatebloodbank.com
- Company type
- Private
- Founded year
- 1949
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Interstate Blood Bank, Inc. (IBBI) is a US-based subsidiary of Grifols, S.A. that operates a network of blood donor centers collecting whole blood from compensated individual donors, screens each donation for infectious diseases at its Memphis, TN testing facility, and supplies the tested product to therapeutic and diagnostic industry buyers.
- Ownership category
- akta.pro rank
Interstate Blood Bank industry classification
Industry- Product category
- Blood Banking Services
- NAICS
- Blood and Organ Banks (621991), Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)
- akta.pro secondary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
Keywords
Where Interstate Blood Bank is headquartered
LocationHeadquarters
- HQ city
- Memphis
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Interstate Blood Bank business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D
Revenue model
- Whole Blood Collection and Distribution: Collects human blood from donors through a network of blood donor centers. The blood is supplied to therapeutic and diagnostic industries for the production of testing and diagnostic tools that contribute to saving and improving lives. Grifols acquired IBBI in 2019.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Donor compensation for time and donation |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Interstate Blood Bank product offering
Product offeringCore offering
Interstate Blood Bank, Inc. (IBBI) collects human whole blood from compensated donors through its network of U.S. donor centers, performs comprehensive pathogen screening at its Memphis, TN testing facility (over 2 million tests annually for Hepatitis B, Hepatitis C, HIV, and Syphilis), and supplies the resulting blood products to therapeutic and diagnostic industries for use in producing testing and diagnostic tools.
Product overview
Interstate Blood Bank, Inc. (IBBI) operates as a network of blood donor centers acquired by Grifols in 2019. The company provides whole blood donation services through its physical donor center locations and supports the therapeutic and diagnostic industries with collected blood products. The core offerings include: the Whole Blood Donation Service (where donors aged 18-70 can donate with compensation), the Blood Donor Center Network (with locations including a Miami facility at Midpoint), and Blood Testing Services (state-of-the-art Memphis, TN facilities performing over 2 million tests annually for Hepatitis B, Hepatitis C, HIV, and Syphilis). This is a single-service healthcare offering, not a platform architecture.
Differentiator
Problem solved
Functional benefit
Products and services
- Whole Blood Donation Service A blood donation service where healthy individuals aged 18-70 who weigh at least 110 lbs can donate whole blood at IBBI donor centers. The donation process takes approximately 30 minutes, donors are compensated for their time, and donors cannot donate more than once in any 8-week period. Collected donations are screened and supplied to therapeutic and diagnostic industries.
- Blood Donor Center Network A network of physical blood donor centers operated by IBBI across the United States where individual donors can donate whole blood. Locations are searchable by ZIP code on the company website, walk-ins are welcome, and centers include a new Miami facility at Midpoint shopping area.
- Blood Testing Services
Quantifiable outcome
- Over 2 million tests performed annually on collected donations
Companies that use Interstate Blood Bank
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Interstate Blood Bank technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Interstate Blood Bank partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Grifols, S.A.coreGrifols acquired Interstate Blood Bank, Inc. (IBBI) and its network of blood donor centers in 2019. As a subsidiary of Grifols, IBBI collects human blood to support the therapeutic and diagnostic industries in the production of testing and diagnostic tools. Grifols is a company since 1909 that develops, produces and markets innovative medicines, solutions and services in more than 110 countries.
Scale indicators2 records
Recent moves4 records
Expansion highlights3 records
Interstate Blood Bank competitors and assessment
Company assessmentDirect peers
- American Red Cross Biomedical Services: Largest U.S. nonprofit blood collector supplying approximately 40% of the nation's blood supply. Comparable in operating blood donor centers and supplying blood products downstream, but relies on volunteer donors, giving it a structural cost advantage over compensated collectors like IBBI.
- BioLife Plasma Services: Subsidiary of Takeda that operates a large U.S. network of for-profit plasma donation centers, paying donors for their time. Closely comparable business model to IBBI's whole-blood donor center network with similar direct-to-donor GTM and compensated donor base.
- Octapharma Plasma: U.S. subsidiary of Octapharma AG operating a network of for-profit plasma donation centers paying donors per donation. Directly comparable donor-compensation business model and downstream supply into therapeutic and diagnostic product manufacturing.
- Vitalant: One of the largest nonprofit blood collection organizations in the U.S., operating donation centers that supply blood products to hospitals and industry. Comparable in core blood collection activity but differs in nonprofit/volunteer model vs IBBI's compensated donor approach.
- CSL Plasma: Subsidiary of CSL Limited operating one of the world's largest plasma collection networks with hundreds of U.S. donor centers. Directly comparable for-profit, compensated-donor collection model that supplies plasma for downstream fractionation into therapeutic and diagnostic products.
Broad incumbents
- Grifols, S.A. Public parent company of IBBI and one of the world's largest plasma-derived therapy companies. Directly comparable as it operates a global plasma collection network and fractionates plasma into therapeutic and diagnostic raw materials, encompassing the full value chain that IBBI feeds into.
- Kedrion Biopharma: Global plasma-derived therapy company that operates its own plasma collection network in the U.S. and internationally. Comparable as both a collector and a downstream fractionator, providing an integrated alternative to IBBI/Grifols' supply chain.
- Bio Products Laboratory (BPL): Plasma collector and fractionator with U.S. donation centers and global therapeutic product distribution. Comparable in operating compensated donor centers and supplying plasma-derived therapeutic and diagnostic materials.
Regional players
- New York Blood Center: Large nonprofit blood collector serving the greater New York region with collection, testing, and distribution operations. Comparable in core blood-bank activity and testing infrastructure but regional in geographic scope and nonprofit in structure.
Others
- Haemonetics Corporation: Medical device company providing blood and plasma collection technology, software, and disposables used by donor centers globally. Comparable as an adjacent ecosystem participant whose products enable the operation of blood collection networks like IBBI's.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Interstate Blood Bank social profiles
Digital presenceInterstate Blood Bank financial estimates
Financial estimateRevenue estimate
Valuation estimate
Interstate Blood Bank leadership team
Management profileNumber of profiles
Profiles1 record
Interstate Blood Bank funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Interstate Blood Bank M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Interstate Blood Bank
What does Interstate Blood Bank do?
Interstate Blood Bank, Inc. (IBBI) collects human whole blood from compensated donors through its network of U.S. donor centers, performs comprehensive pathogen screening at its Memphis, TN testing facility (over 2 million tests annually for Hepatitis B, Hepatitis C, HIV, and Syphilis), and supplies the resulting blood products to therapeutic and diagnostic industries for use in producing testing and diagnostic tools.
Is Interstate Blood Bank a public or private company?
Interstate Blood Bank is a private company. It is classified as corporate owned and is currently operating.
When was Interstate Blood Bank founded?
Interstate Blood Bank was founded in 1949. It employs 251 to 500 people.
Where is Interstate Blood Bank based?
Interstate Blood Bank is headquartered in Memphis, United States, in the North America region.
How does Interstate Blood Bank make money?
One revenue line is on record: whole Blood Collection and Distribution.
Who are Interstate Blood Bank's main competitors?
Direct peers on record are American Red Cross Biomedical Services, BioLife Plasma Services, Octapharma Plasma, Vitalant and CSL Plasma. Broad incumbents are Grifols, S.A., Kedrion Biopharma and Bio Products Laboratory (BPL). New York Blood Center is listed as a regional player. Haemonetics Corporation is listed as an others.
Does Interstate Blood Bank have an API?
No public API is recorded for Interstate Blood Bank.
What industry is Interstate Blood Bank in?
Interstate Blood Bank's product category is Blood Banking Services. Its primary akta.pro industry code is HLAFAMAG, Transfusion Medicine & Immunohematology (Blood Bank), with a secondary code of HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 8071.